Table 2 Comparison of classification performance with three types of markers in the uterine leiomyoma cancer dataset
Classifiers | Markers | Sensitivity | Specificity | Accuracy |
|---|---|---|---|---|
kNN | genes | 93.75 | 92.97 (2.21) | 93.36 (1.1) |
pathways | 92.97 (2.21) | 93.75 | 93.36 (1.1) | |
pathway-sets | 93.75 | 93.75 | 93.75 | |
RF | genes | 90.62 (3.34) | 93.75 | 93.36 (1.1) |
pathways | 92.97 (2.21) | 92.97 (2.21) | 92.19 (1.45) | |
pathway-sets | 93.75 | 92.97 (2.21) | 93.36 (1.1) | |
SVM | genes | 93.75 | 92.19 (2.89) | 92.97 (1.45) |
pathways | 92.97 (2.21) | 93.75 | 93.75 | |
pathway-sets | 93.75 | 93.75 | 93.75 | |
Naïve Bayes | genes | 93.75 | 92.19 (2.89) | 92.97 (1.45) |
pathways | 93.75 | 93.75 | 93.75 | |
pathway-sets | 93.75 | 93.75 | 93.75 |